Related Experiment Video
Updated: Apr 6, 2026
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
How good is our neonatal BCG uptake? A snapshot in Grampian
1NHS Grampian, Aberdeen AB156RE, UK.
Insights
The UK
Area of Science:
- Public Health
- Immunology
- Pediatrics
Background:
- The Neonatal Bacillus Calmette-Guérin (BCG) Immunisation programme is crucial for tuberculosis (TB) control in the UK.
- Variability exists in BCG programme delivery and performance monitoring.
- Infant identification and BCG uptake in at-risk neonates require assessment.
Purpose of the Study:
- To review the identification of infants at risk of TB exposure in Grampian.
- To assess the uptake of BCG vaccination among eligible infants in Grampian.
Main Methods:
- Reviewed Practitioner Services database and Scottish Immunisation Recall System records.
- Included all babies born in Grampian during 2012 and 2013.
- Identified babies with recorded TB risk status and assessed BCG immunization uptake in at-risk infants.
Main Results:
- Over 95% of babies had their TB risk status recorded in 2012 and 2013.
- BCG vaccination uptake in at-risk infants was high, reaching 85.9% in 2012 and 89.9% in 2013.
Conclusions:
- NHS Grampian demonstrates an efficient system for identifying infants at risk of TB exposure.
- Neonatal BCG vaccination coverage in Grampian is good, indicating effective TB control measures.
Background:
The Neonatal BCG Immunisation programme is a key part of tuberculosis (TB) control efforts in the UK; however, there is considerable variability in the method of delivery of the programme and monitoring of performance. This study aimed to review the extent to which infants at risk of exposure to TB are being identified in Grampian and to assess the uptake of BCG vaccination in eligible infants.
Methods:
The Practitioner Services database and Scottish Immunisation Recall System records for all babies born in Grampian in 2012 and 2013 were reviewed to identify the number of babies who had a TB risk status recorded and to assess the uptake of BCG immunization in at-risk babies.
Results:
The proportion of babies with a risk status recorded was 96.6% in 2012 and 95.5% in 2013. The uptake of BCG vaccination in at-risk babies was 85.9% in 2012 and 89.9% in 2013.
Conclusions:
NHS Grampian has an efficient method for identifying infants at risk of exposure to TB and has good neonatal BCG vaccination coverage.
